France Agency Seeks Data from Roche on Use of Avastin in Macular Degeneration
ANSM wants company data on the benefits and risks of using Avastin over Lucentis in the treatment of wet age-related macular degeneration. More... |
| |
Perrigo Agrees to Acquire Omega Pharma for $4.5 Billion
The deal between the two companies will strengthen Perrigo’s presence in Europe. More... |
| |
| PharmTech Europe Marks 25 Years of Drug Development |
Biosimilar Development: 10 Years On
With a number of branded biologics hanging at the patent cliff, the future looks promising for biosimilars. More... |
| |
Emerging Opportunities with Biosimilars
To realise the full potential for biosimilars, stakeholders must build a better understanding of biosimilars and to take a comprehensive view of how these important medicines can fit into treatment pathways. More... |
| |
| Blog |
Combination Products Challenge Biopharma Manufacturers
Most new injectable drugs and biologics are being designed as combination therapies, presenting difficult regulatory and production issues for manufacturers. More... |
| |
| Industry News |
M&A Activity in Pharma Still Strong Despite New Tax Rules
M&A transactions accounted for nearly $15 billion more this year than for the same period a year ago. More... |
| |
Roche Announces 450 Million Swiss Franc Investment on New Facility
Roche announced it will spend 450 million Swiss Francs on a new manufacturing facility in Suzhou, China. More... |
| |
Novo Nordisk Builds New Labs in Denmark, Adds to US Staff
Construction has started on Novo Nordisk's laboratories for diabetes research in Denmark. More... |
| |
Hikma Pharmaceuticals Warned About CGMP Violations at Portuguese Facility
An FDA warning letter to Hikma Pharmaceuticals cites violations of CGMP at its plant in Portugal that manufactures finished drugs. More... |
| |
Seven Steps to Solving Tabletting and Tooling Problems—Step 2: Assess
The importance of “assessing” and how this step will help avoid any problems that may occur during tablet manufacture is discussed. More... |
| |
MedImmune Acquires Definiens
MedImmune enters into an agreement to acquire the image analysis and data mining company. More... |
| |
FDA Grants Orphan Drug Designation to Pancreatic Cancer Treatment
FDA gives orphan drug designation to Merrimack Pharmaceuticals’ MM-141 for the treatment of pancreatic cancer. More... |
| |
AstraZeneca Enters Collaboration with Pharmacyclics and Janssen to Test Hematologic Cancer Treatment
AstraZeneca announced a partnership with Pharmacyclics and Janssen for combination trials of MEDI4736 (AstraZeneca) with Imbruvica (Pharmacyclics and Janssen) for the treatment of hematologic cancers. More... |
| |
